Journal
BIOCHEMICAL JOURNAL
Volume 375, Issue -, Pages 1-16Publisher
PORTLAND PRESS LTD
DOI: 10.1042/BJ20030048
Keywords
5-aminoimidazole-4-carboxamide ribonucleoside; (AICAR); 5 '-AMP-activated protein kinase (AMPK); diabetes mellitus; glucose homoeostasis; insulin secretion; pancreatic islet beta-cell
Categories
Funding
- Diabetes UK [13/0004672] Funding Source: Medline
Ask authors/readers for more resources
AMPK (5'-AMP-activated protein kinase) is emerging as a metabolic master switch. by which cells in both mammals and lower organisms sense and decode changes in energy status. Changes in AMPK activity have been shown to regulate glucose transport in muscle and glucose production by the liver. Moreover, AMPK appears to be a key regulator of at least one transcription factor linked to a monogenic form of diabetes mellitus. As a result, considerable efforts are now under way to explore the usefulness of AMPK as a therapeutic target for other forms of this disease. Here we review this topic, and discuss new findings which Suggest that AMPK may play roles in regulating insulin release and the survival of pancreatic islet beta-cells, and nutrient sensing by the brain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available